Ebastine

依巴斯汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEbastine
Drug Alias NameEbastina艾巴斯汀Bromselon依巴斯丁Ebastinum +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsChronic UrticariaUrticariaEczema +[6] 
Global Approved IndicationsChronic UrticariaUrticariaEczema +[6] 
Approved Indications in ChinaUrticariaEczemaDermatitis +[5] 
Original Approved Country/TerritorySpain
Original Approved Date1990/01/01
Country/TerritorySpainMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsChronic UrticariaUrticariaEczema +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeR06AX22
Related LinksWikipediaKEGG